Dramatic Response to Teriprilumab and Anlotinib Combination Therapy in a patient with EGFR-Mutant Lung Adenocarcinoma Who Experienced Small-Cell Transformation−Mediated Erlotinib Resistance After Failure of Chemotherapy

Bibliographic Details
Published in:	JTO Clinical and Research Reports
Main Authors:	Yuling Zhou, MS, Liang Zeng, MS, Nong Yang, MS, Yongchang Zhang, MD
Format:	Article
Language:	English
Published:	Elsevier 2020-06-01
Subjects:	Anlotinib Teriprilumab EGFR Erlotinib Small cell lung cancer transformation
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666364320300102

Internet